Cysteine and hydrogen sulphide in the regulation of metabolism: Insights from genetics and pharmacology

Journal of Pathology

Volumn 238, Issue 2, 2016, Pages 321-332

  Carter, Roderick N ^a   Morton, Nicholas M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

adipose, liver; cysteine; diabetes; genetic models; insulin resistance; metabolism; obesity; sulphide

Indexed keywords

CYSTEINE; GLUCOSE; HYDROGEN SULFIDE; METHIONINE; SULFUR; TAURINE; GLUCOSE BLOOD LEVEL; INSULIN;

ADIPOSE TISSUE; CATABOLISM; DESULFURIZATION; DIABETES MELLITUS; DNA MODIFICATION; ENZYME SYNTHESIS; GENETIC MODEL; GLUCONEOGENESIS; HUMAN; LIPID OXIDATION; LIPID STORAGE; METABOLIC REGULATION; METABOLISM; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; GENETICS; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; RAT; SECRETION (PROCESS); TRANSGENIC MOUSE;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CYSTEINE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HYDROGEN SULFIDE; INSULIN; INSULIN-SECRETING CELLS; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; MICE; MICE, TRANSGENIC; MODELS, GENETIC; OBESITY; RATS;

EID: 84951304641     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4659     Document Type: Review

References (117)

1. World Health Organization FSN-Oao, 2015: http://www.who.int/mediacentre/factsheets/fs311/en/ [accessed 5 November 15].
2. World Health Organization FSN-Oao, 2015: http://www.who.int/mediacentre/factsheets/fas312/en/ [accessed 5 November 15].
3. Ohlson LO, Larsson B, Svardsudd K, et al., The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34: 1055-1058.
4. Kahn SE, Hull RL, Utzschneider KM,. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846.
5. Stefan N, Haring H-U, Hu FB, et al., Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabet Endocrinol 2013; 1: 152-162.
6. Schaffer JE,. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003; 14: 281-287.
7. Boren J, Taskinen M-R, Olofsson S-O, et al., Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med 2013; 274: 25-40.
8. Weinberg JM,. Lipotoxicity. Kidney Int 2006; 70: 1560-1566.
9. Herman MA, Peroni OD, Villoria J, et al., A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 2012; 484: 333-340.
10. Taskinen M-R, Boren J,. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis 2015; 239: 483-495.
11. El-Khairy L, Ueland PM, Nygard O, et al., Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr 1999; 70: 1016-1024.
12. El-Khairy L, Vollset SE, Refsum H, et al., Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland Homocysteine Study. Clin Chem 2003; 49: 113-120.
13. Elshorbagy AK, Nurk E, Gjesdal CG, et al., Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? Am J Clin Nutr 2008; 88: 738-746.
14. Elshorbagy AK, Kozich V, Smith AD, et al., Cysteine and obesity: consistency of the evidence across epidemiologic, animal and cellular studies. Curr Opin Clin Nutr Metab Care 2012; 15: 49-57.
15. Aasheim ET, Elshorbagy A, Diep LM, et al., Effect of bariatric surgery on sulfur amino acids and glutamate. Br J Nutr 2011; 106: 432-440.
16. Elshorbagy AK, Valdivia-Garcia, Mattocks DAL, et al., Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase. J Lipid Res 2011; 52: 104-112.
17. McGavigan AK, O'Hara HC, Amin A, et al., l -Cysteine suppresses ghrelin and reduces appetite in rodents and humans. Int J Obes (Lond) 2015; 39: 447-455.
18. Elshorbagy AK, Church C, Valdivia-Garcia M, et al., Dietary cystine level affects metabolic rate and glycaemic control in adult mice. J Nutr Biochem 2012; 23: 332-340.
19. Jain SK, Micinski D, Huning L, et al., Vitamin D and l -cysteine levels correlate positively with GSH and negatively with insulin resistance levels in the blood of type 2 diabetic patients. Eur J Clin Nutr 2014; 68: 1148-1153.
20. Whiteman M, Gooding KM, Whatmore JL, et al., Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia 2010; 50: 1722-1726.
21. Jain SK, Bull R, Rains JL, et al., Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation. Antioxid Redox Signal 2010; 12: 1333-1337.
22. 2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol 2008; 294: R1930-1937.
23. Goodwin LR, Francom D, Dieken FP, et al., Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies and two case reports. J Anal Toxicol 1989; 13: 105-109.
24. Abe K, Kimura H,. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16: 1066-1071.
25. Jhee KH, Kruger WD,. The role of cystathionine β-synthase in homocysteine metabolism. Antioxid Redox Signal 2005; 7: 813-822.
26. Braunstein AE, Goryachenkova EV, Tolosa EA, et al., Specificity and some other properties of liver serine sulphydrase: evidence for its identity with cystathionine γ-synthase. Biochim Biophys Acta 1971; 242: 247-260.
27. 2S production in murine tissues. Antioxid Redox Signal 2011; 15: 363-372.
28. Singh S, Padovani D, Leslie RA, et al., Relative contributions of cystathionine B-synthase and g-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J Biol Chem 2009; 284: 22457-22466.
29. Shibuya N, Tanaka, Yoshida M, et al., 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 2009; 11: 703-714.
30. Mikami Y, Shibuya N, Kimura Y, et al., Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem J 2011; 439: 479-485.
31. Goubern M, Andriamihaja M, Nubel T, et al., Sulfide, the first inorganic substrate for human cells. FASEB J 2007; 21: 1699-1709.
32. Hildebrant TM, Grieshaber MK, et al., Three enzymatic activities catalyse the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J 2008; 275: 3352-3361.
33. Libiad M, Yadav PK, Vitvitsky V, et al., Organization of the human mitochondrial hydrogen sulfide oxidation pathway. J Biol Chem 2014; 289: 30901-30910.
34. Feng CJ, Tollin G, Enemark JH,. Sulfite oxidizing enzymes. Biochim Biophys Acta 2007; 1774: 527-539.
35. Gardlik S, Rajgopalan KV,. Oxidation of molybdopterin in sulphite oxidase by ferricyanide. Effect on electron transfer activities. J Biol Chem 1991; 266: 4889-4895.
36. Vitvitsky V, Yadav PK, Kurthen A, et al., Sulfide oxidation by a noncanonical pathway in red blood cells generates thiosulfate and polysulfides. J Biol Chem 2015; 290: 8310-8320.
37. Nicholls P, Kim JK,. Sulphide as an inhibitor and electron donor for the cytochrome c oxidase system. Can J Biochem 1982; 60: 613-623.
38. Nicholls P, Marshall DC, Cooper CE, et al., Sulfide inhibition of and metabolism by cytochrome c oxidase. Biochem Soc Trans 2013; 41: 1312-1316.
39. Cicone JS, Petronis JB, Embert CD, et al., Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004; 43: 1104-1108.
40. Munchberg U, Anwar A, Mecklenburg S, et al., Polysulfides as biologically active ingredients of garlic. Org Biomol Chem 2007; 5: 1505-1518.
41. Keller DA, Menzel DB,. Effects of sulfite on glutathione S-sulfonate and the glutathione status of lung cells. Chem Biol Interact 1989; 70: 145-156.
42. Owczarz M, Arosio P,. Sulfate anion delays the self-assembly of human insulin by modifying the aggregation pathway. Biophys J 2014; 104: 197-207.
43. Carballal S, Trujillo M, Cuevasanta E, et al., Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest. Free Radic Biol Med 2011; 50: 196-205.
44. Kimura Y, Kimura H,. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 2004; 18: 1165-1167.
45. Whiteman M, Li L, Kostetski I, et al., Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 2006; 343: 303-310.
46. Lo Faro ML, Fox B, Whatmore JL, et al., Hydrogen sulfide and nitric oxide interactions in inflammation. Nitric Oxide 2014; 41: 38-47.
47. Li Q, Lancaster JR Jr., Chemical foundations of hydrogen sulfide biology. Nitric Oxide 2013; 35: 21-34.
48. 2S biology. Arch Biochem Biophys 2011; 516: 146-153.
49. 2S. Handb Exp Pharmacol 2015; 230: 29-59.
50. Nagahara N, Nirasawa T, Yoshii T, et al., Is novel signal transducer sulfur oxide involved in the redox cycle of perrsulfide at the catalytic site cysteine in a stable reaction intermediate of mercaptopyruvate sulfurtransferase? Antioxid Redox Signal 2012; 16: 747-753.
51. Zhang L, Yang G, Untereiner A, et al., Hydrogen sulfide impairs glucose utilization and increases gluconeogenesis in hepatocytes. Endocrinology 2013; 154: 114-126.
52. Wu D, Zheng N, Qi K, et al., Exogenous hydrogen sulfide mitigates the fatty liver in obese mice through improving lipid metabolism and antioxidant potential. Med Gas Res 2015; 5: 1-8.
53. Hine C, Harputlugil E, Zhang Y, et al., Endogenous hydrogen sulfide production is essential for dietary restriction benefits. Cell 2015; 160: 132-144.
54. Feng X, Chen Y, Zhao J, et al., Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun 2009; 380: 153-159.
55. Manna P, Jain SK,. Hydrogen sulfide and l -cysteine increase phosphatidylinositol 3,4,5-triphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Ced(PKCed) in 3T3L1 adipocytes. J Biol Chem 2011; 286: 39848-39859.
56. Xue R, Hao D-D, Sun J-P, et al., Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes. Antioxid Redox Signal 2013; 19: 5-23.
57. Pan Z, Wang H, Liu Y, et al., Involvement of CSE/H2S in high glucose induced aberrant secretion of adipokines in 3 T3-L1 adipocytes. Lipids Health Dis 2014; 13: 1-7.
58. Tsai C-Y, Peh MT, Feng W, et al., Hydrogen sulfide promotes adipogenesis in 3T3L1 cells. PLoS One 2015; 10: 1-16.
59. Geng B, Cai B, Liao F, et al., Increase or decrease hydrogen sulfide exert opposite effect lipolysis, but reduce global insulin resistance in high fatty diet induced obese mice. PLoS One 2013; 8: 1-11.
60. Whiteman M, Perry A, Zhou Z, et al., Phosphinodithioate and phosphoramidodithioate hydrogen sulfide donors. Handb Exp Pharmacol 2015; 230: 337-363.
61. 2S in rat insulin-secreting cells and the underlying mechanisms. J Physiol 2005; 569: 519-531.
62. ATP channel-dependent pathway. J Endocrinol 2007; 195: 105-112.
63. Kaneko Y, Kimura Y, Kimura H, et al., l -Cysteine inhibits insulin release from the pancreatic β cell. Diabetes 2006; 56: 1391-1397
64. Nakatsu D, Horiuchi Y, Kano F, et al., l -Cysteine reversibly inhibits glucose-induced biphasic insulin secretion and ATP production by inactivating PKM2. Proc Natl Acad Sci USA 2015; 112: E1067-E1076
65. Kaneko Y, Kimura T, Taniguchi S, et al., Glucose-induced production of hydrogen sulfide may protect the pancreatic β-cells from apoptotic cell death by high glucose. FEBS Lett 2009; 583: 377-382.
66. Patel MA, Shah GB,. Possible role of hydrogen sulfide in insulin secretion and in development of insulin resistance. J Young Pharm 2010; 2: 148-151
67. Paul BD, Sbodio JI, Xu R, et al., Cystathione γ-lyase deficiency mediates neurodegeneration in Huntington's disease. Nature 2014; 509: 96-100.
68. 2+ channels and insulin secretion in mouse pancreatic β cells. Diabetologia 2013; 56: 533-541.
69. Mustafa AK, Sikka G, Gazi SK, et al. Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res 2011; 11: 1259-1268.
70. Yang G, Tang G, Zhang L, et al., The pathogenic role of cystathionine γ-lyase/hydrogen sulfide in streptozotocin-induced diabetes in mice. Am J Pathol 2011; 179: 869-879.
71. 2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting beta cells. J Biol Chem 2007; 282: 16567-16576.
72. Okamoto M, Yamaoka, Takei M, et al., Endogenous hydrogen sulfide protects pancreatic β-cells from a high-fat diet-induced glucotoxicity and prevents the development of type 2 diabetes. Biochem Biophys Res Commun 2013; 442: 227-233.
73. Yusuf M, Kwong Huat BT, Hsu A, et al., Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun 2005; 333: 1146-1152.
74. 2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol 2008; 155: 673-680.
75. Peake BF, Nicholson CK, Lambert JP, et al., Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. Am J Physiol Heart Circ Physiol 2013; 304: H1215-1224.
76. 2S and suppressed insulin release in Zucker diabetic rats. Lab Invest 2009; 89: 59-67.
77. Okamoto M, Ishizaki T, Kimura T, et al., Protective effect of hydrogen sulfide on pancreatic β-cells. Nitric Oxide 2015; 46: 32-36.
78. Elshorbagy A., Body composition in gene knockouts of sulfur amino acid-metabolizing enzymes. Mamm Genome 2014; 25: 455-463.
79. Watanabi M, Osada J, Aratani Y, et al., Mice deficient in cystathionine B-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 1995; 92: 1585-1589.
80. Jensen KK, Geoghagen NS, Jin L, et al., Pharmacological activation and genetic manipulation of cystathionine β-synthase alter circulating levels of homocysteine and hydrogen sulfide in mice. Eur J Pharmacol 2011; 650: 86-93.
81. Wang L, Chen X, Tang B, et al., Expression of mutant human cystathionine B-synthase rescues neonatal lethality but not homocystinuria in a mouse model. Hum Mol Genet 2005; 14: 2201-2208.
82. Ishii I, Akahoshi N, Yamada H, et al., Cystathionine γ-lyase-deficient mice require dietary cysteine to protect against lethal myopathy and oxidative injury. J Biol Chem 2010; 285: 26358-26368.
83. Mani S, Yang G, Wang R,. A critical life-supporting role for cystathionine γ-lyase in the absence of dietary cysteine supply. Free Radic Biol Med 2011; 50: 1280-1287.
84. Akahoshi N, Kobayashi C, Ishizaki Y, et al., Genetic background conversion ameliorates semi-lethality and permits behavioural analyses in cystathionine B-synthase-deficient mice, an animal model for hyperhomocysteinemia. Hum Mol Genet 2008; 17: 1994-2005.
85. Gupta S, Kruger WD,. Cystathionine β-synthase deficiency causes fat loss in mice. PLoS One 2011; 6: 1-10.
86. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ-lyase. Science 2008; 24: 587-590.
87. Shirozu K, Tokuda K, Marutani E, et al., Cystathionine γ-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure. Antioxid Redox Signal 2014; 20: 204-216.
88. Ureland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease and drug therapy: J Lab Clin Med 1989; 114: 473-501.
89. Lee JI, Londono M, Hirschberger LL, et al., Regulation of cysteine dioxygenase and γ-glutamylcysteine synthetase is associated with hepatic cysteine level. J Nutr Biochem 2004; 15: 112-122.
90. Gupta S, Kuhnisch J, Mustafa A, et al., Mouse models of cystathionine B-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J 2009; 23: 883-893.
91. Mani S, Hongzhu L, Untereiner A, et al., Decrease endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation 2013; 127: 2523-2534.
92. Akahoshi N, Kamata S, Kubota M, et al., Neutral aminoaciduria in cystathionine β-synthase-deficient mice, an animal model of homocystinuria. Am J Physiol Renal Physiol 2014; 306: F1462-1476.
93. Robert K, Nehme J, Bourdon E, et al., Cystathionine β-synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 2005; 128: 1405-1415.
94. Hamelet J, Demuth K, Paul J-L, et al., Hyperhomocysteinemia due to cystathionine β-synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J Hepatol 2007; 46: 151-159.
95. Namekata K, Enokido Y, Ishii I, et al., Abnormal lipid metabolism in cystathionine β-synthase-deficient mice, an animal model for hyperhomocysteinemia. J Biol Chem 2004; 279: 52961-52969.
96. Nagahara N, Yoshii T, Abe Y, et al., Thioredoxin-dependent enzymatic activation of mercaptopyruvate sulfurtransferase. An intersubunit disulfide bond serves as a redox switch for activation. J Biol Chem 2007; 282: 1561-1569.
97. Nagahara N, Nagano M, Ito T, et al., Antioxidant enzyme, 3-mercaptopyruvate sulfurtransferase-knockout mice exhibit increased anxiety-like behaviors: a model for human mercaptolactate-cysteine disulfiduria. Sci Rep 2013; 3: 1-7.
98. Jacobs RL, Zhao Y, Koonen DPY, et al., Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity. J Biol Chem 2010; 285: 22403-22413.
99. Wu G, Zhang L, Li T, et al., Choline supplementation promotes hepatic insulin resistance in phosphatidylethanolamine N-methyltransferase-deficient mice via increased glucagon action. J Biol Chem 2013; 288: 837-847.
100. Noga AA, Stead LM, Zhao Y, et al., Plasma homocysteine is regulated by phospholipid methylation. J Biol Chem 2003; 278: 5952-5955.
101. Teng Y-W, Ellis JM, Coleman RA, et al., Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissue. J Biol Chem 2012; 287: 16187-16198.
102. Kimura H., Hydrogen sulfide and polysulfides as biological mediators. Molecules 2014; 19: 16146-16157.
103. -/- mice. Toxicol Appl Pharmacol 2011; 257: 338-348.
104. Haque JA, McMahan RS, Campbell JS, et al., Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice. Lab Invest 2010; 90: 1704-1717.
105. Lieberman MW, Wiseman AL, Shi Z-Z, et al., Growth retardation and cysteine deficiency in γ-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci USA 1996; 93: 7923-7926.
106. Ueki I, Roman HB, Valli A, et al., Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am J Physiol Endocrinol Metab 2011; 301: E668-684.
107. - production and evidence of pancreatic and lung toxicity. Antioxid Redox Signal 2013; 19: 1321-1336.
108. Park E, Park SY, Dobkin C, et al., Development of a novel cysteine sulfinic acid decarboxylase knockout mouse: dietary taurine reduces neonatal mortality. J Amino Acids 2014; 2014: 346809.
109. 35S-sulphide in the rat. Biochem Pharmacol 1972; 21: 2313-2321.
110. Tiranti V, Viscomi C, Hildebrant T, et al., Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 2009; 15: 200-205.
111. Jackson MR, Melideo SL, Jorns MS,. Human sulfide: quinone oxidoreductase catalyzes the first step in hydrogen sulfide metabolism and produces a sulfane sulfur metabolite. Biochemistry 2012; 51: 6804-6815.
112. Grings M, Moura AP, Parmeggiani B, et al., Disturbance of brain energy and redox homeostasis provoked by sulfite and thiosulfate: potential pathomechanisms involved in the neuropathology of sulfite oxidase deficiency. Gene 2013; 531: 191-198.
113. Emerson B, Carter R, Morton NM, et al., Cardiovascular phenotyping in mice with thiosulfate sulfurtransferase gene knock-out. Nitric Oxide 2013; 31: S39-40.
114. Shen X, Peter EA, Bir S, et al., Analytical measurement of discrete hydrogen sulfide pools in biological specimens. Free Radic Biol Med 2012; 52: 2276-2283.
115. Olson KR, DeLeon ER, Liu F,. Controversies and conundrums in hydrogen sulfide biology. Nitric Oxide 2014; 41: 11-26.
116. Elrod JW, Calvert JW, Morrison J, et al., Hydrogen sulfide attenuates myocardial ischemia-reperfersion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007; 104: 15560-15565.
117. 2S induces a suspended animation-like state in mice. Science 2005; 308: 518.